Lurasidone Hydrochloride Tablet, Film Coated
Product Images NDC 33342-420

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Lurasidone Hydrochloride (NDC 33342-420). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

765 (Lurasidone 120 mg 30s)

Label for lurasidone hydrochloride tablets 120 mg, film coated, oral dosage form. The label is from Macleods Pharmaceuticals Limited and Macleods Pharma USA, Inc. It shows the strength 120 mg prominently and includes storage instructions, dosage notice, and manufacturing details. The package contains 30 tablets.*

FDA Label Image

567 (Lurasidone 120 mg 90s)

Label for Lurasidone Hydrochloride Tablets, 120 mg film-coated oral tablets, supplied in a 90-tablet package. The label includes storage instructions, manufacturer details as Macleods Pharma USA, Inc., and Macleods Pharmaceuticals Ltd. It also notes the dosage information should be referred to package insert and provides barcode and regulatory codes.*

FDA Label Image

111 (Lurasidone 20 mg 30s)

Label for Lurasidone Hydrochloride Tablets 20 mg, film coated oral tablets. The label includes the NDC 33342-419-07 and manufacturer information for Macleods Pharma USA, Inc., Princeton, NJ and Macleods Pharmaceuticals Ltd., India. It states the dosage, storage instructions, and a pharmacist dispensing note. The package contains 30 tablets.*

FDA Label Image

222 (Lurasidone 20 mg 90s)

Label for Lurasidone Hydrochloride Tablets 20 mg by Macleods Pharmaceuticals Limited. The label indicates film-coated tablets containing 20 mg of Lurasidone Hydrochloride. The label includes storage instructions, manufacturer details (Macleods Pharma USA, Inc.), and barcode information. The package contains 90 tablets.*

FDA Label Image

333 (Lurasidone 40 mg 30s)

Label for Lurasidone Hydrochloride Tablets 40 mg film-coated oral tablets by Macleods Pharmaceuticals Limited. The label includes storage instructions, dosage reference to the package insert, and manufacturing information for Macleods Pharma USA, Inc. It states the quantity as 30 tablets and features barcodes and a designated 'OPZ AREA' space on the right side.*

FDA Label Image

555 (Lurasidone 40 mg 90s)

Label for Lurasidone Hydrochloride Tablets 40 mg film coated tablets by Macleods Pharmaceuticals Limited. The label includes dosage information, storage conditions, manufacturer details (Macleods Pharma USA, Inc. and Oxalis Labs, India), and package quantity of 90 tablets. It features barcodes and instructions to dispense the accompanying medication guide.*

FDA Label Image

666 (Lurasidone 60 mg 30s)

Label for Lurasidone Hydrochloride Tablets 60 mg film-coated tablets by Macleods Pharmaceuticals Limited. The label includes dosage strength, manufacturer information, storage instructions, and a pharmacist dispensing notice. It lists NDC 33342-421-07 and indicates a package size of 30 tablets.*

FDA Label Image

666 (Lurasidone 60 mg 90s)

Label for lurasidone hydrochloride 60 mg film-coated tablets, oral. The label includes directions for storage between 20° to 25°C with permitted excursions, dosage reference to package insert, manufacturer Macleods Pharmaceuticals Limited, and distributor Macleods Pharma USA, Inc. The packaging indicates 90 tablets and provides an NDC barcode and code number.*

FDA Label Image

888 (Lurasidone 80 mg 30s)

Lurasidone Hydrochloride Tablets 80 mg film-coated oral tablets label by Macleods Pharmaceuticals Limited. The label includes NDC 33342-422-07 and states pharmacist instructions to dispense the medication guide to each patient. The package contains 30 tablets and advises storage between 20° to 25°C with excursions allowed between 15° to 30°C. Manufactured for Macleods Pharma USA, Inc., Princeton, NJ, and by Macleods Pharmaceuticals Ltd. in India.*

FDA Label Image

123 (Lurasidone 80 mg 90s)

Packaging label for Lurasidone Hydrochloride tablets, 80 mg strength, film coated oral tablets. The label includes the NDC code 33342-422-10, manufacturer Macleods Pharma USA, Inc., and states the product contains 90 tablets. Storage instructions and dosing guidance to refer to the package insert are also shown. The label highlights the active ingredient and strength prominently in black and green text.*

FDA Label Image

198 (Lurasidone Fig 1)

A horizontal dot plot chart illustrating the impact of various interacting drugs on the pharmacokinetics of lurasidone hydrochloride. The x-axis represents fold change relative to lurasidone alone, ranging from -4 to 4. The y-axis lists interacting drugs grouped by their CYP3A4 inhibition or induction strength with measures for Cmax and AUC fold changes and 90% confidence intervals depicted as horizontal error bars.*

FDA Label Image

111 (Lurasidone Fig 2)

A pharmacokinetic interaction chart illustrating fold change and 90% confidence intervals for various interacting drugs relative to their values when administered alone. It includes data on P-gp substrates (Digoxin), CYP3A4 substrates (Midazolam), oral contraceptives (Ethinyl Estradiol, Norelgestromin), and Lithium, showing changes in Cmax, AUC, and Ctrough values.*

FDA Label Image

122 (Lurasidone Fig 3)

A scatter plot with error bars showing fold change and 90% confidence intervals (CI) in pharmacokinetic parameters (Cmax and AUC) for lurasidone hydrochloride by degrees of renal impairment, hepatic impairment, gender, and race. The x-axis represents change relative to reference with values ranging from 0 to 6. Subgroups include mild, moderate, and severe impairment categories, females, and Asians compared to Caucasians.*

FDA Label Image

115 (Lurasidone Structure)

Chemical structure diagram of lurasidone hydrochloride showing molecular bonds and groups including a bicyclic ring, piperazine, and thiophene components, along with the hydrochloride (HCl) salt.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.